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Apoptosis in pancreatic necropsy tissues in CF 
U. 0 zc2elik l, B. Talim 2, E. 3aal~in l, M. ~aglar 2, D. Dogr ul, A. Asian l, N. Kiper l
~Pulrrmnary Medicine Unit, 2 Pathology Unit, Department of Pediatrics, University 
of Hacettepe, Ankara, Turkey 
Aims: Apoptorir ir a phyriological procerr which limitr tirrue injury and ir 
conridered an er sential requirement for the rerolution of an ilfflammatory erponre. 
Although it hat been demonrtrated that CFFR may alto control apoptorir of 
epithelial cellr, apopt orir ha the pancrear of CF patient r ir not well known. Aimr of 
thir rtudy were to compare the apoptotic ell countr ha the pancreatic necropry 
tirruer of CF and control rubject r and to rearch any relation between apopt orir and 
hislopathological grade of pancreatic direase and ilfflammation. 
Methods: H&E rtained archived rlider of pancreatic tissues obtained from 
autoprier of 17 CF patientr (mean age 13 monthr) and 8 caret of comparable age 
group with normal pancrear hit tology, non metabolic, non pancreatic dir order were 
examined. Severity of pathological changer in the pancrear war graded from 1 to 4. 
The pretence of il flammation war graded ar absent o severe. DNA fragmentation 
war determined by TUNEL array and proliferating cellr were arrerred by Ki67 
poritivity by immtmccyt cchemir try. The number of apopt otic cellr war determined 
by counting the percentage ofTUNEL poritive aciner or ductular epithelial cellr. 85 
fieldr were evaluated for each care under high power magnification; TUNEL and 
Ki67 poritive cellr were counted. 
Results: Although the percentage ofapoptotic ellr were higher in CF than contr air 
(0.18 and 0.09, rerpectively) no rtatirtically rignificant difference war found. Alto 
there war no cat, elation between the hirtopathological grade, ilfflammation and 
apoptorir in CF pancreatic tirruer. 
Conclusion: Apoptorir reemr not to be rignificantly increared ha pancrear of CF 
patient r; however, we believe that thir ir due to rmall number of included patientr. 
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Increased concenkafion of alphal-antitrypsin in the stool of CF 
pafients: an indirect marker of impaired intestinal integrity in CF 
H. Tom~ov~, D. Zemkov~, J. Barto~ov~, V. Skalick~, M. Macek Jr, V. V~wov~ 
National CF Centre, Charles University- 2nd School of Medicine and University 
Hospital Moral, Prague, Czech Republic 
Quantification of alfa 1 antitryprin (A1AT) excretion ha stool ir an eslablirhed 
method for monitoring of the illflammatory bowel disease, degree of 
hypoalbuminemia and for the estimation of enteric protein loss. In the case of 
impaired integrity of intertinal mucora the plasmatic protein A1AT penetrater 
through the intestinal wall and ir thur detected in stool. A1AT (examined by a 
r tandard immuncchemical method) and Elartare 1 (El) (ELISA Test; BioServAG). 
were determined in the stool from 139 CF patients aged 0.1 46.8 (median 8.8) 
yearr and in 157 controls aged 0.01 26.9 (median 8.1 ) yearr without any hit tory of 
pancreatic and/or gartrointertinal disease. The nutritional status (NS) of rtudied 
patients war assessed by anthropometric examination compared to Czech 
population rtandardr. CF patients were divided into two groupr according to fecal 
El: a/ 21 pancreatic rufficient caret with E1 > 200 ~tg/g and b/ 118 pancreatic 
inrufficient caret with E1 < 200 ~tg/g rtool. A 1AT concentr ationr in contr air ranged 
between 0.04 0.51 [median 0.13; 10 t~ percentile 0.05; 90 t~ percentile 0.21]. ha CF 
patientr A1AT concentration war rignificantly higher between 0.05 1.5 [median 
0.18; 10 ~ percentile 0.1; 90 t~ percentile 0.3]. Pancreatic rufficient and inrufficient 
patientr did not differ rignificantly and there war no relation to the level of rweat 
chloride concentrationr, nutritional rtatur and/or lung fimction. In conclurion, our 
rerultr provide vidence of impaired integrity of intertinal mucora in both 
pancreatic insufficient and rufficient CF patientr. 
Supported by MZCR -VZFNM ~0064203 wM 8236-3 
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Fecal elastase concentration in patients with cysfic fibrosis - 
comparison of a monoclonal with a new polyclonal ELISA 
B. Funk 1, A. Schneider 2,W. Carpary 2, M. Pohl 1, J. Stein 2 
Johann Wolfgang Goethe-University Germany, ~Department of Pediatric 
Gastroenterology, 2Department of lnternaI Medicine I 
Introduction: Assessment of exccrine pancreatic function ir routinely performed 
uring the fecal concentration of elaslare 1. The enzyme can be arrerred both with 
an ert ablirhed monoclonal ELISA (n~T (Schebo Biotech AG, Germany)) or with a 
newly developed polyclonal ELISA (pET (BioServ Diagnostics, Germany)). We 
compared both tests ha patients with cy slic fibrosis and under different conditions of 
sample storage. 
Methods: Fecal elartare war mearured with both ELISAr in stool samples of two 
different patient groups: 
1)Stool samples from 27 CF Patients under pancreatic enzyme rubrtitution (5.(~) 
to 10.0(X) IE porcine pancreatil~Jkg/d) 
2) Stool samples of 10 pancreatic rufficient patients were divided in 4 aliquot r: one 
sample war terted irectly after defacation, the other 3 samples were rtored at 4°C, 
room temperature (22°C) mad 37°C. and analyred after 24 h and 48 h with both 
arrayr.Additionaly one sample of a patient with pancreatic inrufficiency war 
analyred for elartare before and after the addition of I(X) IU mad 3(X) IU porcine 
pancreatin. 
Resufls: Elartare concentrations of the pET in CF patientr differed rignificantly 
from those of the mET (137,7+68,6 yr. 4,3+9,0 gg/g, p<0,(X)01). Among the other 
rubgroupr the r sults of the pET were rignificantly higher after 48 hourr at 4°C 
(p~),(X)4) whereas the other analyrer teemed rimilar under room temperature or
37°C. The analyrir of the single stool thawed oredependant higher results for pET 
compared to mET. Discussion: Our results tugger t that he pET ir ilffluenced by oral 
pancreatic enzyme rubr titution. A possible explanation for thir finding could be an 
antigenic rpecificity of the pET rignificantly different from elartare 1. 
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Frequency of laryngopharyngeal reflux symptoms in pafients with 
cystic fibrosis 
T.M. Moon, G.M. Smith, J.R. Ramr ay, C.F. Everett, J.A. Kar telik, A.H. Morice 
Academic Department of Respiratory Medicine, Postgraduate Medical Institute, 
University of Hull 
Introduction: Cough i ra  common and dirtrerring rymptom in patient r with cystic 
fibrorir. In patientr with rerpiratory conditionr, laryngopharyngeal reflux ir 
frequently arrociated with chronic cough. However, the prevalence of 
laryngopharyngeal reflux in cyrtic fibrorir hat not been widely rtudied. 
Aim: To determine the frequency of laryngopharyngeal reflux rymptomr in patient r 
with cyrtic fibrorir. 
Methods: Patientr with cyrtic fibrorir completed a validated 5 point Likett rcale 
reflux rymptom quertionnaire. The total rcore and the rcorer for individual 
rymptomr were calculated for each patient. The total par rible rcore ranged from 0 
45, with the higher t valuer indicating agreater degree of laryngopharyngeal reflux. 
A rcore of 14 or above indicated a rignificant degree of laryngopharyngeal reflux. 
Results: 14 (4 female) patientr, median (range) age 23.5 (18 54) yearr completed 
the questionnaire. The total score war 17.5 (4 26). 11 patient r (79%) rcored higher 
than 14 ruggerting rignificant laryngopharyngeal reflux. Overall 71% patientr 
complained of rignificant broat clearing, 50% of excerr mucur ha the throat or a 
rent ation of pormaral drip, 71% of cough on lying down and only 43% of clarrical 
heartburn. In addition, cough on tir ing from bed (a typical rymptom of 
laryngopharyngeal reflux) war reported by 50% of patient r.
Conclusion: Laryngopharyngeal reflux rymptomr are frequently reported by 
patientr with cyrtic fibrorir. A rimple quertiommire can be ured to identify 
laryngopharyngeal reflux allowing thir common treatable caure of cbr onic cough to 
be diagnored. 
